-
EP2239578
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2239578
| EP2239578 - Method for determining the survival prognosis of patients suffering from non-small cell lung cancer (NSCLC) [Right-click to bookmark this link] | Status | The application has been refused Status updated on 03.06.2011 Database last updated on 19.07.2024 | Most recent event Tooltip | 03.06.2011 | Refusal of application | published on 06.07.2011 [2011/27] | Applicant(s) | For all designated states PamGene B.V. Nieuwstraat 30 5211 NL 's Hertogenbosch / NL | [N/P] |
| Former [2010/41] | For all designated states PamGene B.V. Nieuwstraat 30 5211 's Hertogenbosch / NL | Representative(s) | De Clercq, Ann G. Y., et al De Clercq & Partners cvba Edgard Gevaertdreef 10 a 9830 Sint-Martens-Latem / BE | [2010/41] | Application number, filing date | 09157816.1 | 10.04.2009 | [2010/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2239578 | Date: | 13.10.2010 | Language: | EN | [2010/41] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 29.07.2009 | Classification | IPC: | G01N33/574, C12Q1/48 | [2010/41] | CPC: |
G01N33/57423 (EP,US);
C12Q1/485 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/41] | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | Verfahren zur Bestimmung der Überlebensprognose von Patienten mit nicht-kleinzelligem Lungenkrebs (NSCLC) | [2010/41] | English: | Method for determining the survival prognosis of patients suffering from non-small cell lung cancer (NSCLC) | [2010/41] | French: | Procédé pour déterminer le pronostic de survie des patients souffrant d'un cancer du poumon à grandes cellules | [2010/41] | Examination procedure | 18.02.2011 | Despatch of communication that the application is refused, reason: Examination on filing A.90(5) [2011/27] | 28.02.2011 | Application refused, date of legal effect [2011/27] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.04.2011 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2008049930 (JANSSEN PHARMACEUTICA NV [BE], et al) [X] 10-14 * claims 1,33-39 * * examples 1,2,4,6 * * page 9, line 9 - line 38 * * table 1; sequences 8,11,16,28,46,47,64,68,75,77,86-88,91 * * table 1; sequences 112,131,133,136 *; | [X]WO2007005027 (CELL SIGNALING TECHNOLOGY INC [US], et al) [X] 10,13 * example 5 * * paragraph [0030] *; | [A] - TANG J M ET AL, "Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis", LUNG CANCER, ELSEVIER, AMSTERDAM, NL, vol. 51, no. 2, ISSN 0169-5002, (20060201), pages 181 - 191, (20060201), XP024893851 [A] 1-9,15 * abstract * DOI: http://dx.doi.org/10.1016/j.lungcan.2005.10.003 | [A] - VANMETER AMY J ET AL, "Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer DIFFERENTIAL EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PHOSPHORYLATION EVENTS ASSOCIATED WITH MUTATED EGFR COMPARED WITH WILD TYPE", MOLECULAR & CELLULAR PROTEOMICS, (200810), vol. 7, no. 10, ISSN 1535-9476, pages 1902 - 1924, XP008108477 [A] 1-9 * abstract * | by applicant | WO0119517 |